IBD Patient Risk

IBD Patient Risk image indicating  General Public Health Risk (Under 65 years old and on lower risk medications), Medium Risk (65-70 years old using immunosuppressive medications) and High Risk (Oer 70 years old using cortticosteroids with Active disease)

Listed below are the details pertaining to the three sections.

Low Risk Icon
Profil de MII
  • Moins de 65 ans 
    et ne prenant pas  
    d’immunosuppresseurs ou de médicaments biologiques
  • MII en rémission, pas d’inflammation active importante
  • Pas de malnutrition
  • Pas de comorbidités (respiratoires, cardiaques, hypertension, diabète)
Follow public health guidelines for general population (Distanciation physique1, hygiène des mains, autosurveillance, etc.)
Medium Risk icon
Profil de MII
  • Moins de 65 ans 
    et sous traitement par immunosuppresseurs ou médicaments biologiques2 :
  • Moins de 65 ans et sous traitement par immunosuppresseurs ou médicaments biologiques2  :
    • Immunomodulateurs : azathioprine (Imuran), 6-mercaptopurine (Purinethol), méthotrexate
    • Produits biologiques anti-TNF : infliximab (Remicade®, Inflectra®, RenflexisMC), adalimumab (Humira®), golimumab (Simponi®)
    • Produits biologiques anti-IL12/23 : ustekinumab (Stelara®)
    • Produits biologiques anti-migration leucocytaire : vedolizumab (Entyvio®)
    • Petites molécules inhibitrices de JAK : tofacitinib (Xeljanz®)
In addition to following public health guidelines for general population (physical distancing1, hand hygiene, self-monitoring, etc.):
  • Évitez les rencontres en personne
  • Si possible, travaillez de la maison et utilisez les technologies virtuelles pour organiser des réunions
  • Si ce n’est pas possible, parlez à votre médecin et examinez les options de tâches modifiées avec votre employeur3
  • Utilisez les services réservés aux personnes vulnérables pour éviter tout contact avec d’autres personnes
High Risk Icon
Profil de MII
de 65 ans OU moins de 65 ans ET  
  • Corticothérapie à action générale par voie orale ou intraveineuse ≥ 20 mg/jour (ou ≥ 0,5 mg/kg chez les enfants) :
    • Prednisone (Deltasone)
    • Methylprednisolone
    • Hydrocortisone (Hydrocort, Cortate)
  • Inflammation active modérée à grave (nouveau diagnostic ou poussée récente)
  • Malnutrition modérée à graven
  • Alimentation parentérale nécessaire (alimentation intraveineuse par voie centrale)
In addition to following public health guidelines for general population (physical distancing1, hand hygiene, self-monitoring, etc.):
  • Auto-isolation4
  • Autres membres de la famille5


    • Keep a distance of 2 metres from the nearest person
    • If possible, cancel group events and hold meetings virtually rather than in-person
    • Avoid people who are sick
    • Do not shake hands, hug, or engage in physical contact with other people, especially if they are sick
    • Practice good hand hygiene. Wash your hands with soap and water regularly after social contact, before meals, and often in between, or use hand sanitizer that contains at least 60% alcohol when soap and water is not available. Avoid touching your face. Cough into your sleeve.
  1. Please note that not everyone is at the same risk of serious COVID-19 disease. For example, children and adolescents are more likely to have mild symptoms of COVID-19. We don’t know whether children and adolescents on immunosuppressive medications have a higher risk of COVID-19 complications. Therefore, we have considered everyone on immunosuppressive medications to be vulnerable for serious COVID-19 disease.  
  1. People working in essential services in the Medium Risk group (such as health care providers) should consider balance the public need for these essential services with the higher risk of contracting COVID-19. Further guidance can be provided by your local public health authority.
  1. Self-isolation means:
    • stay at home and monitor yourself for symptoms, even if mild, for 14 days
    • avoid contact with others
    • If you have no symptoms of COVID-19, you can still go outside for:
      • fresh air
      • a run
      • a bike ride
      • to walk the dog
  1. Considerations for other family members and people who live with high risk individuals. In general:
    • avoid being in close proximity with other people, who might give your family member COVID-19, resulting in transmission to you 
    • Try to avoid in-person meetings
    • Try to work from home. If not possible, speak to your employer about physical distancing at work
    • Use services for vulnerable people (e.g. special grocery store times, pharmacy delivery, etc.)
    • Clean your residence as best as possible to avoid transmission of the virus. Instructions for disinfecting your residence are available from the Centers for Disease Control and Prevention 
    • While doing these activities, always maintain a distance of at least 2 arms-length (approximately 2 metres) from others.
    • Refer to our guidance for more information on how to self-isolate at home when you may have been exposed and have no symptoms.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.